SIGLEC1 and neoplasm: To understand what causes the unique CD169+ phenotype on distinct TAM populations in human breast tumors (9, 22), we next evaluated different inflammatory or tumor-derived mediators on primary human Mo-M, in an in vitro M2 tumor microenvironment-setting.